Cargando…
Clinical update on linezolid in the treatment of Gram-positive bacterial infections
Gram-positive pathogens are a significant cause of morbidity and mortality in both community and health care settings. Glycopeptides have traditionally been the antibiotics of choice for multiresistant Gram-positive pathogens but there are problems with their use, including the emergence of glycopep...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392139/ https://www.ncbi.nlm.nih.gov/pubmed/22787406 http://dx.doi.org/10.2147/IDR.S25890 |